Pathway Financial Advisers
LLY icon

Pathway Financial Advisers’s Eli Lilly LLY Stock Holding History

Pathway Financial Advisers’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.44M Buy
2,972
+80
+3% +$94.4K 0.86% 39
2026
Q2 		$3.47M Buy
2,892
+101
+4% +$103K 0.87% 40
2026
Q1 		$2.57M Buy
2,791
+278
+11% +$282K 0.73% 50
2025
Q4 		$2.7M Sell
2,513
-23
-0.9% -$22K 0.78% 46
2025
Q3 		$1.88M Buy
2,536
+749
+42% +$557K 0.55% 64
2025
Q2 		$1.39M Buy
1,787
+123
+7% +$95.6K 0.45% 75
2025
Q1 		$1.37M Buy
1,664
+478
+40% +$398K 0.47% 72
2024
Q4 		$915K Buy
1,186
+1,185
+118,500% +$981K 0.31% 94
2024
Q3 		$1.15K Sell
1
-1,100
-100% -$989K ﹤0.01% 371
2024
Q2 		$982K Buy
1,101
+44
+4% +$35.2K 0.35% 90
2024
Q1 		$823K Buy
1,057
+82
+8% +$58.4K 0.3% 99
2023
Q4 		$568K Buy
975
+99
+11% +$57.8K 0.22% 114
2023
Q3 		$471K Buy
+876
New +$451K 0.19% 118
2023
Q1 		$323K Sell
940
-250
-21% -$84.3K 0.13% 139
2022
Q4 		$436K Buy
+1,190
New +$422K 0.18% 119

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Pathway Financial Advisers's LLY Position: Q3 2026 in Review

Pathway Financial Advisers increased its Eli Lilly (LLY) stake by 2.8% in Q3 2026, buying an estimated $94.4K and bringing the position to 2,972 shares worth $3.44M. The position accounts for 0.86% of the portfolio, ranked #39.

Pathway Financial Advisers first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.47M in Q2 2026. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Pathway Financial Advisers held 2,972 shares of Eli Lilly worth $3.44M as of Q3 2026.
  • Pathway Financial Advisers bought 80 Eli Lilly shares in Q3 2026, an estimated $94.4K.
  • Eli Lilly made up 0.86% of Pathway Financial Advisers's portfolio in Q3 2026, its #39 holding.
  • Pathway Financial Advisers first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • Pathway Financial Advisers's Eli Lilly position peaked at $3.47M in Q2 2026.
  • 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Pathway Financial Advisers's 13F filing for Q3 2026, filed 27 Oct 2026.